Travere Therapeutics Inc.

NASDAQ: TVTX · Real-Time Price · USD
18.82
0.59 (3.24%)
At close: Aug 15, 2025, 3:59 PM
19.25
2.28%
After-hours: Aug 15, 2025, 05:00 PM EDT

Travere Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-169M -225.9M -320.73M -349.06M -410.08M -426.06M -376.33M -353.56M -307.44M -288.84M -278.48M -264.23M -230.22M -202.19M -180.09M -250.14M -237.05M -224.11M
Depreciation & Amortization
50.15M 46.48M 43.55M 43.32M 37.67M 41.23M 40.89M 38.34M 41.33M 35.53M 33.08M 29.83M 29.12M 27.64M 26.62M 27.2M 25.77M 25M
Stock-Based Compensation
39.38M 38.65M 36.91M 35.84M 38.55M 40.53M 44.25M 45.63M 43.72M 44.46M 39.18M 38.23M 36.38M 31.04M 30.77M 28.54M 26.95M 25.61M
Other Working Capital
-5.98M -72.76M -62.43M -50.97M -53.09M 14.97M 446K -19.89M -11.84M -16.91M -9.78M 8.78M 45.55M 51.08M 63.28M 41.77M 15.4M 11.07M
Other Non-Cash Items
-36.63M 64.75M 90.37M 194.98M 189.55M 96.2M 99.81M -6.82M 1.91M 6.2M 18.91M 18.56M 31.31M 30.2M 23.82M 126.2M 116.9M 118.71M
Deferred Income Tax
n/a n/a n/a -109.42M -59.84M -63.17M -63.17M 46.26M -3.33M n/a n/a 1.44M 2.5M 2.67M 4.12M 2.71M 2.84M 2.89M
Change in Working Capital
663K -60.07M -63.02M -63.32M -60.14M -6.35M -25.48M -34.03M -20.77M -9.85M 904K 17.54M 43.84M 67.01M 79.98M 63.7M 37.48M 11.84M
Operating Cash Flow
-115.44M -160.66M -237.47M -272.23M -288.86M -317.91M -280.02M -264.19M -244.58M -212.09M -186.29M -158.53M -86.94M -43.64M -14.79M -1.78M -27.11M -40.06M
Capital Expenditures
-3.2M -14.96M -9.64M -5.61M -29.55M -20.76M -42.26M -40.93M -43M -51.26M -28.56M -29.56M -27.3M -20.15M -24.15M -122.83M -124.37M -124.5M
Cash Acquisitions
n/a n/a n/a 12.65M 18.21M 21.41M 48.75M 36.1M 20.46M 17.26M -4.94M 9.06M 24.16M 28.37M 28.01M 27.04M 26.52M 26.45M
Purchase of Investments
-190.13M -125.76M -125.76M -62.65M -218.28M -340.75M -443.94M -465.58M -404.52M -462.3M -385.39M -346.04M -347.61M -324.52M -547.08M -574.1M -584.22M -458.81M
Sales Maturities Of Investments
243.92M 268.13M 326.33M 321.29M 354.67M 351.82M 334.57M 336.96M 361.54M 411.4M 381.99M 387.12M 408.87M 345.92M 433.6M 426.43M 362.4M 376.73M
Other Investing Acitivies
-50.42M -103.48M -98.08M -109.45M 118.36M 179.53M 158.66M 169.47M -21.69M -56.95M -34.75M -48.16M -63.26M -28.37M -28.01M -27.04M -26.52M -26.45M
Investing Cash Flow
11.96M 35.72M 99.33M 162.68M 249.88M 197.71M 55.78M 36.02M -87.21M -102.76M -32.55M 11.52M 33.96M 1.25M -137.62M -270.5M -346.19M -206.58M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 95.44M 95.44M 95.44M 95.44M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.14M 3.45M -793K -144K -253K 1.23M 27.55M 27.98M 30.89M 29.46M 2.59M 4.47M 4.61M 4.18M 6.75M 6.53M 3.71M 3.46M
Financial Cash Flow
144.36M 143.66M 139.42M 427K -253K 1.23M 218.75M 219.18M 222.09M 220.66M 117.57M 150.24M 150.37M 149.84M 231.68M 223.51M 220.75M 329.24M
Net Cash Flow
42.86M 18.65M 359K -107.83M -38.58M -118.13M -3.51M -7.09M -108.89M -95.2M -104.06M 1.01M 96.47M 108.34M 80.98M -50.15M -153.88M 81.21M
Free Cash Flow
-118.28M -175.26M -246.76M -277.48M -318.4M -338.67M -322.28M -305.11M -287.58M -263.35M -214.85M -188.09M -114.24M -63.79M -38.94M -124.62M -151.49M -164.56M